Rationale and design of the phase 2b clinical trials to study the effects of the partial adenosine A1-receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced (PANTHEON) and preserved (PANACHE) ejection fraction
scientific article published on 17 September 2018
Author/s
author: Mihai Gheorghiade, Javed Butler, Jeroen Joost Bax, Adriaan A Voors, John McMurray, Adrian F. Hernandez, Sanjiv J Shah, Dalane W Kitzman, Michael van der Laan, Antonieta Bomfim Wirtz
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.